Clinical Trial Update: NSCLC Burden of Illness Study

View source ↗

Summary

This GlaxoSmithKline-sponsored NSCLC burden of illness study has completed, providing an update on the clinical trial assessing the burden of illness in non-sma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lung Cancer, Non-Small Cell | Status: COMPLETED